Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. - Wikidata - wikimedia - TriplyDB

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial.

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial.

http://www.wikidata.org/entity/Q34761643

about

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review Neoadjuvant treatment for rectal cancer-A value-based proposition.Adjuvant chemotherapy Outcomes of rectal cancer with liver oligometastases Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer Copy number alterations and allelic ratio in relation to recurrence of rectal cancer Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients.Advances and challenges in treatment of locally advanced rectal cancer.Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.Neo-adjuvant radiotherapy in rectal cancer.SEOM Clinical Guideline of localized rectal cancer (2016).On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery.Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?The multidisciplinary approach to the treatment of rectal cancer: 2015 update.Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?Neoadjuvant treatment for locally advanced rectal cancer: a systematic review.Radiotherapy and locally advanced rectal cancer.Update on advances and controversy in rectal cancer treatment.Current topics in the multimodality treatment of locally advanced rectal cancer.Systematic review and meta-analysis of the role of metronidazole in post-haemorrhoidectomy pain relief.Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design.Total neoadjuvant therapy for rectal cancer: An emerging option.Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational database Time trends, improvements and national auditing of rectal cancer management over an 18-year period.Correlation Between Preoperative Serum Carcinoembryonic Antigen Levels and Expression on Pancreatic and Rectal Cancer Tissue.Trial Watch: Radioimmunotherapy for oncological indications.Adjuvant chemotherapy for patients with ypT0-2N0-category after neoadjuvant chemoradiotherapy for rectal cancer.What treatments should be skipped or intensified in localized rectal cancer?Response to Heedman et al.: Variation at presentation among colon cancer patients with metastases: a population-based study.[Optimal fractionation regimen, and time between radiotherapy and operation in rectal cancer : The multicenter, randomized Stockholm III trial].Preoperative short course radiotherapy with concurrent and consolidation chemotherapies followed by delayed surgery in locally advanced rectal cancer: preliminary results.Contemporary management of locally advanced rectal cancer: Resolving issues, controversies and shifting paradigms.Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study.Assessment of testicular dose during preoperative radiotherapy for rectal cancer.Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer.Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy.

P2860

Q26739607-B7F93AC2-EDCB-4045-BA5D-716FE54C21E4 Q26785539-E1420147-BF2C-43DD-A7CD-135661CE6B2A Q30251516-77D8ED41-99E4-4D3F-A89F-E29B722C9480 Q33698724-CC95D109-AFD2-45D9-9472-D84F2459BB06 Q34484282-2A95613A-40DC-49FD-8817-3B6359DDD20C Q34630015-DE078AAC-292B-4104-822C-FC615CE27FED Q34719568-CC820DF2-45DF-4A96-AE35-0FDBFFA28913 Q34995307-2F883EEE-EB95-4437-93DC-D9B442D952CF Q35655094-B7C66D7E-5069-49AE-A46E-F4371A5E813E Q35781562-1AC007E1-F4E3-4301-ACC6-77CA29C387D6 Q36025983-19980FCA-20BF-4C6C-967C-94B8079AFADA Q36348179-ADB2FD70-C375-4353-8254-F96C6423837E Q36807950-1ED5FD2F-BCBC-463F-960B-232F29EF99FC Q37408813-FFD53A03-D561-4C04-B419-42C415B5948A Q37475229-84505D40-3BC7-41CE-A219-39DA1F8FECB3 Q37715201-E17EECFA-0C79-438D-8E29-A2F561AD6029 Q38208009-A9145015-381D-4077-B9C1-05954383CE6A Q38272299-41303886-6D39-4DA8-A52E-5651E784394C Q38322257-214F8DF1-9DFD-4E8C-B171-76689D4A006C Q38546385-E83D95A0-5352-486C-A95C-35CFFE2D8AF4 Q38604995-65097567-01ED-4119-BBF1-39FBC637F95D Q38692803-930DC41C-2A7D-4B21-919F-8E962B7CD19A Q38734893-4B391475-A1D3-4E1D-8B14-A1840C2D236F Q39154629-4915AE7A-1F55-447A-973E-A4E2E6118D63 Q39172475-09A8CA3E-CFAD-4760-987B-01CD548B0617 Q39179402-B33E29A9-20DD-4E49-B359-550D2407249D Q40481695-414844F3-26BC-41AE-AC7C-D167FBA7349F Q40757558-42134423-6301-476E-98E6-F2EE651D4850 Q42255560-E50D0124-D73D-4449-B3FE-A9E999228B52 Q43104064-56E43AFB-E117-4E02-8BAC-46545084820B Q47205433-41BDA5BE-8FD5-44AC-B6EB-AF0018A7705D Q47741303-3A99B4F3-F5CF-4159-A5CE-37C3474B8A0C Q48149311-695A8302-0242-48BB-B538-870E80B08945 Q50534444-033DF393-D505-40DD-B43D-38573C0EFAE4 Q52330786-68EA183A-1512-4BF2-8F65-B3F779A32D47 Q52653160-5D518407-43F0-48BF-9C80-594B26E8057A Q53172925-FB8DA4D8-0716-40E3-8298-9AD4014C30F5 Q53353937-941F2A5E-1FB7-430E-B62D-64FD4A79895C Q54114270-3CAD3B26-E8CF-4C12-8997-8ABF0DB4137A Q54117909-DCF1E2F4-84FE-41A7-B85E-83C98829CE74

P2860

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial.

http://www.wikidata.org/entity/Q34761643

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@ast

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@en

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@nl

type

label

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@ast

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@en

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@nl

prefLabel

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@ast

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@en

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@nl

P1433

Q34761643-B5AE5FE7-90A7-4228-9046-9D025E5D58DA

P1476

Q34761643-4C4C31BE-061D-4B47-8BD1-B0B11A9039C0

P2093

Q34761643-0FC3365F-6CA9-4849-BF62-66995A30A42F

Q34761643-15CF8BCB-8F1E-42AB-BEE9-D5699B301B46

Q34761643-3F0F9EA8-9511-4414-B05C-F9D086036FE0

Q34761643-414725FE-422E-4B3E-A6F7-0F9F28A7131F

Q34761643-624B5563-7735-4089-BF7F-05F534DE952A

Q34761643-855E82D3-E078-4634-9324-02B57779558E

Q34761643-94716B32-B177-4C21-B516-8D9B0435373F

Q34761643-B6FD3EF2-41C5-4EFD-A295-CAA2E5C5E018

Q34761643-B9ED26CE-54BC-4C1D-87BD-5717DADB7AD1

Q34761643-C4CD6D24-B470-4810-BE32-C1C8B320154D

P2860

Q34761643-02D93371-E03E-4F2A-B3C4-0D2BA25C19FC

Q34761643-037ED87B-A688-4668-A79C-CB3D901EF56B

Q34761643-04C4A93F-AF77-4AC0-99ED-7FC33C274E76

Q34761643-0AEB5C54-673E-4867-80E2-0AE0AE1CAF00

Q34761643-1042C062-10C3-4F86-89EC-4A31F5BED11C

Q34761643-12EB0A2D-F9EE-4D35-BB71-B945961CA6C8

Q34761643-13565F40-FA3D-4191-9E6F-1F02200213B5

Q34761643-161223FD-DB6F-454F-8AC0-8E7B6ABB06A8

Q34761643-1EDD64E2-214B-4ACA-83E4-275D8A229100

Q34761643-27FADAB5-B249-4208-9931-FB6817422513

P2888

Q34761643-B2D5E558-1A5E-4929-9AC4-89E9290BE4C7

P304

Q34761643-835FAE45-2F67-4206-88ED-ED6E329AA1F3

P31

Q34761643-00D50E0E-8F9D-4481-9366-1C660A7E8F0F

P356

Q34761643-E3126696-2FC6-43EF-9954-8740A6CCD986

P407

Q34761643-4BFA5FA0-B66C-4BD3-AD08-F71E9CA4D46C

P478

Q34761643-B4EB516E-1E4D-43F1-9260-2790A8670CFC

P50

Q34761643-7AB01925-E3C1-41F1-9F9F-B8587C145073

Q34761643-F129407E-2378-41DC-98F8-DB8DC1679066

P577

Q34761643-CE7225AD-C703-434C-A7B5-C45DDCDB1996

P5875

Q34761643-9DF710BD-40E7-4195-937D-C2401B7DF376

P6179

Q34761643-84D375E0-BDA2-458A-BE41-98AD8684556B

P698

Q34761643-3E167E39-0471-491B-B25B-466648CA876F

P921

Q34761643-15D1EA55-03EB-46E6-93D9-17B0361374E5

Q34761643-3A338150-842F-4802-BA7D-50974D0B11B8

P932

Q34761643-59D54700-FCEA-49AF-BD3A-96EEFD2F07A8

P356

1471-2407-13-279

P1433

P1476

Short-course radiotherapy foll ...... ctal cancer--the RAPIDO trial.

@en

P2093

Boudewijn van Etten

http://www.w3.org/2001/XMLSchema#string

Cornelis J H van de Velde

http://www.w3.org/2001/XMLSchema#string

Corrie A M Marijnen

http://www.w3.org/2001/XMLSchema#string

Ellen Kapiteijn

http://www.w3.org/2001/XMLSchema#string

Geke A P Hospers

http://www.w3.org/2001/XMLSchema#string

Jannet C Beukema

http://www.w3.org/2001/XMLSchema#string

Lars Påhlman

http://www.w3.org/2001/XMLSchema#string

Lennart Blomqvist

http://www.w3.org/2001/XMLSchema#string

Per J Nilsson

http://www.w3.org/2001/XMLSchema#string

Regina G H Beets-Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Postoperative adjuvant chemotherapy in rectal cancer operated for cure

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N99

Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

The Swedish rectal cancer registry.

P2888

1471-2407-13-279

P304

279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-279

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Bengt Glimelius

P577

2013-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237068378

http://www.w3.org/2001/XMLSchema#string

P6179

1050773853

http://www.w3.org/2001/XMLSchema#string

P698

23742033

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3680047

http://www.w3.org/2001/XMLSchema#string